Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$22.62 - $39.32 $385,354 - $669,855
-17,036 Reduced 50.71%
16,559 $420,000
Q1 2023

May 12, 2023

BUY
$30.17 - $41.11 $441,598 - $601,727
14,637 Added 77.21%
33,595 $1.21 Million
Q4 2022

Feb 14, 2023

BUY
$36.43 - $49.4 $690,639 - $936,525
18,958 New
18,958 $750,000
Q2 2022

Aug 10, 2022

BUY
$40.85 - $77.67 $79,698 - $151,534
1,951 Added 20.37%
11,528 $505,000
Q1 2022

May 11, 2022

BUY
$59.95 - $92.06 $62,228 - $95,558
1,038 Added 12.16%
9,577 $693,000
Q4 2021

Feb 10, 2022

BUY
$81.07 - $121.29 $238,021 - $356,107
2,936 Added 52.4%
8,539 $692,000
Q3 2021

Oct 28, 2021

BUY
$101.99 - $166.36 $100,562 - $164,030
986 Added 21.36%
5,603 $652,000
Q2 2021

Aug 10, 2021

BUY
$141.6 - $179.06 $169,070 - $213,797
1,194 Added 34.88%
4,617 $765,000
Q1 2021

Jul 21, 2021

BUY
$132.81 - $182.18 $55,514 - $76,151
418 Added 13.91%
3,423 $478,000
Q4 2020

Feb 12, 2021

SELL
$138.17 - $184.34 $2.14 Million - $2.86 Million
-15,516 Reduced 83.78%
3,005 $520,000
Q3 2020

Oct 30, 2020

BUY
$114.09 - $145.51 $689,902 - $879,898
6,047 Added 48.48%
18,521 $2.58 Million
Q2 2020

Aug 05, 2020

BUY
$89.45 - $129.85 $403,866 - $586,272
4,515 Added 56.73%
12,474 $1.49 Million
Q1 2020

May 11, 2020

SELL
$70.23 - $144.31 $11,517 - $23,666
-164 Reduced 2.02%
7,959 $796,000
Q4 2019

Feb 13, 2020

SELL
$76.41 - $117.54 $167,567 - $257,765
-2,193 Reduced 21.26%
8,123 $955,000
Q3 2019

Nov 08, 2019

BUY
$61.52 - $91.1 $634,640 - $939,787
10,316 New
10,316 $887,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $116M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.